tiprankstipranks
Aim Immunotech Inc. (AIM)
XASE:AIM
US Market
Want to see AIM full AI Analyst Report?

AIM ImmunoTech (AIM) Stock Forecast & Price Target

971 Followers
See the Price Targets and Ratings of:

AIM Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
AIM
ImmunoTech
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AIM Stock 12 Month Forecast

There Are No Analyst Ratings for AIM In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

AIM Financial Forecast

AIM Earnings Forecast

The previous quarter’s earnings for AIM were -$1.39.
The previous quarter’s earnings for AIM were -$1.39.

AIM Sales Forecast

The previous quarter’s earnings for AIM were $21.00K.
The previous quarter’s earnings for AIM were $21.00K.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Ascendiant Analyst forecast on AIM
Ascendiant
Ascendiant
$23.98$21.98
Buy
1658.40%
Upside
Reiterated
12/07/25
Current valuation attractive: We are maintaining our Buy rating, but lowering our 12‐month price target to $22 from $24, which is based on a NPV analysis.
Maxim Group Analyst forecast on AIM
Maxim Group
Maxim Group
$5.99
Buy
379.20%
Upside
Initiated
09/05/25
Maxim Group Resumes Coverage with a Buy Rating on AIM ImmunoTech (AIM)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Ascendiant Analyst forecast on AIM
Ascendiant
Ascendiant
$23.98$21.98
Buy
1658.40%
Upside
Reiterated
12/07/25
Current valuation attractive: We are maintaining our Buy rating, but lowering our 12‐month price target to $22 from $24, which is based on a NPV analysis.
Maxim Group Analyst forecast on AIM
Maxim Group
Maxim Group
$5.99
Buy
379.20%
Upside
Initiated
09/05/25
Maxim Group Resumes Coverage with a Buy Rating on AIM ImmunoTech (AIM)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering AIM ImmunoTech

3 Months
xxx
Success Rate
3/8 ratings generated profit
38%
Average Return
+5.08%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 37.50% of your transactions generating a profit, with an average return of +5.08% per trade.
1 Year
Edward WooAscendiant
Success Rate
1/8 ratings generated profit
13%
Average Return
-60.90%
Copying Edward Woo's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -60.90% per trade.
2 Years
xxx
Success Rate
0/8 ratings generated profit
0%
Average Return
-82.14%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -82.14% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AIM Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
2
1
1
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
1
1
0
0
In the current month, AIM has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AIM average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

AIM Stock Forecast FAQ

What is AIM’s average 12-month price target, according to analysts?
Currently, no data Available
What is AIM’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for AIM, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is AIM a Buy, Sell or Hold?
      Currently, no data Available
      What is Aim Immunotech Inc.’s price target?
      Currently, no data Available
      What do analysts say about Aim Immunotech Inc.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of AIM?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.